Phase Ib of L-NMMA and Pembrolizumab
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
University Hospital, Caen
H. Lee Moffitt Cancer Center and Research Institute
Fudan University
Dana-Farber Cancer Institute
Rowan University
UNC Lineberger Comprehensive Cancer Center
Medical College of Wisconsin
University of Colorado, Denver
University of Kentucky
Hospices Civils de Lyon
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
University of Texas Southwestern Medical Center
University of Leipzig
University of California, San Diego
Mayo Clinic
Icahn School of Medicine at Mount Sinai
Heidelberg University
University of California, San Diego
University of Michigan Rogel Cancer Center
CHU de Reims
Xinqiao Hospital of Chongqing
Xinqiao Hospital of Chongqing
Washington University School of Medicine
Hôpital de la Croix-Rousse
University of Pittsburgh
Maastricht University Medical Center
Centre Henri Becquerel
Centre Henri Becquerel
University of Pittsburgh
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts Eye and Ear Infirmary
M.D. Anderson Cancer Center
UNICANCER
Wake Forest University Health Sciences
Washington University School of Medicine
Medical University of South Carolina
Dana-Farber Cancer Institute
University of Southern California
NRG Oncology
Maastricht Radiation Oncology
Centre Antoine Lacassagne
Centre Antoine Lacassagne
Thomas Jefferson University
University of Arkansas
Institut Claudius Regaud
GERCOR - Multidisciplinary Oncology Cooperative Group
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
University of California, San Diego